GO ID | GO:0030198 |
Ontology | BP |
GO Term | extracellular matrix organization |
Definition | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
TNFRSF11B |
tumor necrosis factor receptor superfamily member 11b |
4982 |
O00300 |
chr8: 118,923,557-118,952,200 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
3491 |
O00622 |
chr1: 85,580,761-85,583,962 |
NCAN |
neurocan |
1463 |
O14594 |
chr19: 19,211,973-19,252,233 |
DNAJB6 |
DnaJ heat shock protein family (Hsp40) member B6 |
10049 |
O75190 |
chr7: 157,335,381-157,417,439 |
ITGA10 |
integrin subunit alpha 10 |
8515 |
O75578 |
chr1: 145,891,208-145,910,189 |
ECM2 |
extracellular matrix protein 2, female organ and adipocyte specific |
1842 |
O94769 |
chr9: 92,493,554-92,536,655 |
RECK |
reversion-inducing-cysteine-rich protein with kazal motifs |
8434 |
O95980 |
chr9: 36,036,433-36,124,451 |
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
COL1A1 |
collagen, type I, alpha 1 |
1277 |
P02452 |
chr17: 50,183,289-50,201,632 |
COL3A1 |
collagen, type III, alpha 1 |
1281 |
P02461 |
chr2: 188,974,320-189,012,746 |
FGA |
fibrinogen alpha chain |
2243 |
P02671 |
chr4: 154,583,126-154,590,766 |
FGB |
fibrinogen beta chain |
2244 |
P02675 |
chr4: 154,562,956-154,571,086 |
FGG |
fibrinogen gamma chain |
2266 |
P02679 |
chr4: 154,604,134-154,612,967 |
FN1 |
fibronectin 1 |
2335 |
P02751 |
chr2: 215,360,440-215,436,172 |
TTR |
transthyretin |
7276 |
P02766 |
chr18: 31,591,726-31,599,021 |
VTN |
vitronectin |
7448 |
P04004 |
chr17: 28,367,276-28,373,091 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
VWF |
von Willebrand factor |
7450 |
P04275 |
chr12: 5,948,874-6,124,770 |
APP |
amyloid beta (A4) precursor protein |
351 |
P05067 |
chr21: 25,880,550-26,171,128 |
ITGB3 |
integrin subunit beta 3 |
3690 |
P05106 |
chr17: 47,253,846-47,311,816 |
ITGB2 |
integrin subunit beta 2 |
3689 |
P05107 |
chr21: 44,885,953-44,931,989 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 |
P05121 |
chr7: 101,127,089-101,139,266 |
ICAM1 |
intercellular adhesion molecule 1 |
3383 |
P05362 |
chr19: 10,270,835-10,286,615 |
ITGB1 |
integrin subunit beta 1 |
3688 |
P05556 |
chr10: 32,900,319-33,005,792 |
COL5A2 |
collagen, type V, alpha 2 |
1290 |
P05997 |
chr2: 189,031,896-189,179,879 |
ITGAV |
integrin subunit alpha V |
3685 |
P06756 |
chr2: 186,590,065-186,680,901 |
DCN |
decorin |
1634 |
P07585 |
chr12: 91,140,484-91,183,123 |
LAMB1 |
laminin subunit beta 1 |
3912 |
P07942 |
chr7: 107,923,799-108,003,255 |
THBS1 |
thrombospondin 1 |
7057 |
P07996 |
chr15: 39,581,079-39,599,466 |
COL1A2 |
collagen, type I, alpha 2 |
1278 |
P08123 |
chr7: 94,394,561-94,431,232 |
COL4A2 |
collagen, type IV, alpha 2 |
1284 |
P08572 |
chr13: 110,305,812-110,513,027 |
ITGA5 |
integrin subunit alpha 5 |
3678 |
P08648 |
chr12: 54,395,261-54,419,460 |
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
6678 |
P09486 |
chr5: 151,661,096-151,687,165 |
FURIN |
furin (paired basic amino acid cleaving enzyme) |
5045 |
P09958 |
chr15: 90,868,592-90,883,458 |
SPP1 |
secreted phosphoprotein 1 |
6696 |
P10451 |
chr4: 87,975,650-87,983,426 |
HAPLN1 |
hyaluronan and proteoglycan link protein 1 |
1404 |
P10915 |
chr5: 83,637,805-83,721,613 |
LAMC1 |
laminin subunit gamma 1 |
3915 |
P11047 |
chr1: 183,023,460-183,145,592 |
ITGAM |
integrin subunit alpha M |
3684 |
P11215 |
chr16: 31,259,990-31,332,892 |
COL11A1 |
collagen, type XI, alpha 1 |
1301 |
P12107 |
chr1: 102,876,467-103,108,496 |
COL6A1 |
collagen, type VI, alpha 1 |
1291 |
P12109 |
chr21: 45,981,737-46,005,050 |
COL6A2 |
collagen, type VI, alpha 2 |
1292 |
P12110 |
chr21: 46,098,097-46,132,849 |
COL6A3 |
collagen, type VI, alpha 3 |
1293 |
P12111 |
chr2: 237,324,003-237,414,375 |
VCAN |
versican |
1462 |
P13611 |
chr5: 83,471,465-83,582,303 |
NID1 |
nidogen 1 |
4811 |
P14543 |
chr1: 235,975,830-236,065,162 |
B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
2683 |
P15291 |
chr9: 33,104,082-33,167,356 |
CD44 |
CD44 molecule (Indian blood group) |
960 |
P16070 |
chr11: 35,138,870-35,232,402 |
ITGB4 |
integrin subunit beta 4 |
3691 |
P16144 |
chr17: 75,721,328-75,757,818 |
PECAM1 |
platelet/endothelial cell adhesion molecule 1 |
5175 |
P16284 |
chr17: 64,319,415-64,413,776 |
ITGA2 |
integrin subunit alpha 2 |
3673 |
P17301 |
chr5: 52,989,326-53,094,779 |
ERCC2 |
excision repair cross-complementation group 2 |
2068 |
P18074 |
chr19: 45,349,837-45,370,918 |
ITGB5 |
integrin subunit beta 5 |
3693 |
P18084 |
chr3: 124,761,948-124,901,418 |
VCAM1 |
vascular cell adhesion molecule 1 |
7412 |
P19320 |
chr1: 100,719,742-100,739,045 |
ITGAX |
integrin subunit alpha X |
3687 |
P20702 |
chr16: 31,355,134-31,382,997 |
BCL3 |
B-cell CLL/lymphoma 3 |
602 |
P20749 |
chr19: 44,747,705-44,760,044 |
COL9A1 |
collagen, type IX, alpha 1 |
1297 |
P20849 |
chr6: 70,215,061-70,303,083 |
COL5A1 |
collagen, type V, alpha 1 |
1289 |
P20908 |
chr9: 134,641,774-134,844,843 |
BGN |
biglycan |
633 |
P21810 |
chrX: 153,494,939-153,509,554 |
FBLN1 |
fibulin 1 |
2192 |
P23142 |
chr22: 45,502,238-45,601,135 |
ITGA6 |
integrin subunit alpha 6 |
3655 |
P23229 |
chr2: 172,427,354-172,506,282 |
LAMA2 |
laminin subunit alpha 2 |
3908 |
P24043 |
chr6: 128,883,141-129,516,569 |
TNC |
tenascin C |
3371 |
P24821 |
chr9: 115,019,578-115,118,257 |
COL8A2 |
collagen, type VIII, alpha 2 |
1296 |
P25067 |
chr1: 36,095,236-36,125,220 |
COL5A3 |
collagen, type V, alpha 3 |
50509 |
P25940 |
chr19: 9,959,561-10,010,471 |
ITGA3 |
integrin subunit alpha 3 |
3675 |
P26006 |
chr17: 50,055,968-50,090,481 |
ITGB8 |
integrin subunit beta 8 |
3696 |
P26012 |
chr7: 20,330,702-20,415,754 |
LOX |
lysyl oxidase |
4015 |
P28300 |
chr5: 122,063,195-122,078,360 |
FBN1 |
fibrillin 1 |
2200 |
P35555 |
chr15: 48,408,306-48,645,849 |
FBN2 |
fibrillin 2 |
2201 |
P35556 |
chr5: 128,257,909-128,659,185 |
BSG |
basigin (Ok blood group) |
682 |
P35613 |
chr19: 571,277-583,493 |
SERPINB5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
5268 |
P36952 |
chr18: 63,476,761-63,505,085 |
ITGAE |
integrin subunit alpha E |
3682 |
P38570 |
chr17: 3,714,628-3,801,243 |
COL18A1 |
collagen, type XVIII, alpha 1 |
80781 |
P39060 |
chr21: 45,405,137-45,513,720 |
SOX9 |
SRY-box 9 |
6662 |
P48436 |
chr17: 72,121,020-72,126,420 |
COMP |
cartilage oligomeric matrix protein |
1311 |
P49747 |
chr19: 18,782,773-18,791,314 |
LUM |
lumican |
4060 |
P51884 |
chr12: 91,102,629-91,111,831 |
MFAP2 |
microfibrillar associated protein 2 |
4237 |
P55001 |
chr1: 16,974,502-16,980,835 |
JAM2 |
junctional adhesion molecule 2 |
58494 |
P57087 |
chr21: 25,639,272-25,717,562 |
ADAMTS20 |
ADAM metallopeptidase with thrombospondin type 1 motif 20 |
80070 |
P59510 |
chr12: 43,353,866-43,551,921 |
ELF3 |
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
1999 |
P78545 |
chr1: 202,007,945-202,017,188 |
HSPG2 |
heparan sulfate proteoglycan 2 |
3339 |
P98160 |
chr1: 21,822,245-21,937,297 |
COL4A3 |
collagen, type IV, alpha 3 (Goodpasture antigen) |
1285 |
Q01955 |
chr2: 227,164,565-227,314,792 |
COL10A1 |
collagen, type X, alpha 1 |
1300 |
Q03692 |
chr6: 116,118,923-116,158,747 |
PTK2 |
protein tyrosine kinase 2 |
5747 |
Q05397 |
chr8: 140,657,900-141,002,216 |
COL14A1 |
collagen, type XIV, alpha 1 |
7373 |
Q05707 |
chr8: 120,059,780-120,372,036 |
COL16A1 |
collagen, type XVI, alpha 1 |
1307 |
Q07092 |
chr1: 31,652,247-31,704,319 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
780 |
Q08345 |
chr6: 30,876,421-30,900,156 |
LOXL1 |
lysyl oxidase like 1 |
4016 |
Q08397 |
chr15: 73,925,989-73,952,137 |
CD47 |
CD47 molecule |
961 |
Q08722 |
chr3: 108,043,298-108,091,025 |
PRDX4 |
peroxiredoxin 4 |
10549 |
Q13162 |
chrX: 23,664,262-23,686,399 |
MFAP5 |
microfibrillar associated protein 5 |
8076 |
Q13361 |
chr12: 8,637,346-8,662,888 |
ITGA9 |
integrin subunit alpha 9 |
3680 |
Q13797 |
chr3: 37,452,115-37,823,514 |
COL4A6 |
collagen, type IV, alpha 6 |
1288 |
Q14031 |
chrX: 108,155,607-108,439,497 |
NID2 |
nidogen 2 |
22795 |
Q14112 |
chr14: 52,004,803-52,069,228 |
DAG1 |
dystroglycan 1 |
1605 |
Q14118 |
chr3: 49,468,703-49,535,618 |
POSTN |
periostin, osteoblast specific factor |
10631 |
Q15063 |
chr13: 37,562,583-37,598,844 |
TGFBI |
transforming growth factor beta induced |
7045 |
Q15582 |
chr5: 136,028,895-136,063,818 |
LAMA4 |
laminin subunit alpha 4 |
3910 |
Q16363 |
chr6: 112,108,760-112,254,939 |
LAMA3 |
laminin subunit alpha 3 |
3909 |
Q16787 |
chr18: 23,689,443-23,955,066 |
HSD17B12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
51144 |
Q53GQ0 |
chr11: 43,680,558-43,856,617 |
COL13A1 |
collagen, type XIII, alpha 1 |
1305 |
Q5TAT6 |
chr10: 69,801,931-69,964,275 |
OLFML2A |
olfactomedin like 2A |
169611 |
Q68BL7 |
chr9: 124,777,158-124,814,885 |
ADAMTSL4 |
ADAMTS like 4 |
54507 |
Q6UY14 |
chr1: 150,549,369-150,560,937 |
CCDC80 |
coiled-coil domain containing 80 |
151887 |
Q76M96 |
chr3: 112,596,794-112,649,530 |
NPHP3 |
nephronophthisis 3 (adolescent) |
27031 |
Q7Z494 |
chr3: 132,680,609-132,722,442 |
ERO1B |
endoplasmic reticulum oxidoreductase beta |
56605 |
Q86YB8 |
chr1: 236,215,555-236,281,985 |
TMPRSS6 |
transmembrane protease, serine 6 |
164656 |
Q8IU80 |
chr22: 37,065,436-37,109,563 |
NDNF |
neuron-derived neurotrophic factor |
79625 |
Q8TB73 |
chr4: 121,035,613-121,073,021 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
55790 |
Q8TDX6 |
chr8: 19,404,161-19,758,029 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
9806 |
Q92563 |
chr10: 72,059,035-72,089,032 |
TNR |
tenascin R |
7143 |
Q92752 |
chr1: 175,315,194-175,743,770 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
323 |
Q92870 |
chr4: 40,810,027-41,216,714 |
BCAN |
brevican |
63827 |
Q96GW7 |
chr1: 156,641,390-156,659,532 |
ERO1A |
endoplasmic reticulum oxidoreductase alpha |
30001 |
Q96HE7 |
chr14: 52,639,916-52,695,900 |
KAZALD1 |
Kazal-type serine peptidase inhibitor domain 1 |
81621 |
Q96I82 |
chr10: 101,061,841-101,068,131 |
JAM3 |
junctional adhesion molecule 3 |
83700 |
Q9BX67 |
chr11: 134,068,925-134,152,001 |
CRISPLD2 |
cysteine-rich secretory protein LCCL domain containing 2 |
83716 |
Q9H0B8 |
chr16: 84,819,984-84,920,768 |
SMOC2 |
SPARC related modular calcium binding 2 |
64094 |
Q9H3U7 |
chr6: 168,441,151-168,673,445 |
DSPP |
dentin sialophosphoprotein |
1834 |
Q9NZW4 |
chr4: 87,608,529-87,616,910 |
ITGA11 |
integrin subunit alpha 11 |
22801 |
Q9UKX5 |
chr15: 68,296,533-68,432,162 |
HPSE |
heparanase |
10855 |
Q9Y251 |
chr4: 83,292,461-83,335,153 |
F11R |
F11 receptor |
50848 |
Q9Y624 |
chr1: 160,995,211-161,021,348 |
POMT1 |
protein-O-mannosyltransferase 1 |
10585 |
Q9Y6A1 |
chr9: 131,502,902-131,523,806 |
LAMC3 |
laminin subunit gamma 3 |
10319 |
Q9Y6N6 |
chr9: 131,009,082-131,094,473 |